FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022254839> ?p ?o ?g. }

• W2022254839 endingPage "2717" @default.
• W2022254839 startingPage "2702" @default.
• W2022254839 abstract "The 90 kDa heat shock proteins (Hsp90), which are integrally involved in cell signaling, proliferation, and survival, are ubiquitously expressed in cells. Many proteins in tumor cells are dependent upon the Hsp90 protein folding machinery for their stability, refolding, and maturation. Inhibition of Hsp90 uniquely targets client proteins associated with all six hallmarks of cancer. Thus, Hsp90 has emerged as a promising target for the treatment of cancer. Hsp90 exists as a homodimer, which contains three domains. The N-terminal domain contains an ATP-binding site that binds the natural products geldanamycin and radicicol. The middle domain is highly charged and has high affinity for cochaperones and client proteins. Initial studies by Csermely and co-workers suggested a second ATP-binding site in the Cterminus of Hsp90. This C-terminal nucleotide binding pocket has been shown to not only bind ATP, but cisplatin, novobiocin, epilgallocatechin-3-gallate (EGCG) and taxol. The coumarin antibiotics novobiocin, clorobiocin, and coumermycin A1 were isolated from several streptomyces strains and exhibit potent activity against Gram-positive bacteria. These compounds bind type II topoisomerases, including DNA gyrase, and inhibit the enzyme-catalyzed hydrolysis of ATP. As a result, novobiocin analogues have garnered the attention of numerous researchers as an attractive agent for the treatment of bacterial infection. Novobiocin was reported to bind weakly to the newly discovered Hsp90 C-terminal ATP binding site (∼700 M in SkBr3 cells) and induce degradation of Hsp90 client proteins. Structural modification of this compound has led to an increase of 1000-fold in activity in antiproliferative assays. Recent studies of structure – activity relationship (SAR) by Renoir and co-workers highlighted the crucial role of the C-4 and/or C-7 positions of the coumarin and removal of the noviose moiety, which appeared to be essential for degradation of Hsp90 client proteins. Unlike the N-terminal ATP binding site, there is no reported co-crystal structure of Hsp90 C-terminus bound to any inhibitor. The Hsp90 C-terminal domain, however, is known to contain a conserved pentapeptide sequence (MEEVD) which is recognized by co-chaperones. Cisplatin is a platinum-containing chemotherapeutic used to treat various types of cancers, including testicular, ovarian, bladder, and small cell lung cancer. Most notably, cisplatin coordinates to DNA bases, resulting in cross-linked DNA, which prohibits rapidly dividing cells from duplicating DNA for mitosis. Itoh and co-workers reported that cisplatin decreases the chaperone activity of Hsp90. This group applied bovine brain cytosol to a cisplatin affinity column, eluted with cisplatin and detected Hsp90 in the eluent. Subsequent experiments indicated that cisplatin exhibits high affinity for Hsp90. Moreover Csermely and co-workers determined that the cisplatin binding site is located proximal to the Cterminal ATP binding site. EGCG is one of the active ingredients found in green tea. EGCG is known to inhibit the activity of many Hsp90- dependent client proteins, including telomerase, several kinases, and the aryl hydrocarbon receptor (AhR). Recently Gasiewicz and co-workers reported that EGCG manifests its antagonistic activity against AhR through binding Hsp90. Similar to novobiocin, EGCG was shown to bind the C-terminus of Hsp90. Unlike previously identified N-terminal Hsp90 inhibitors, EGCG does not appear to prevent Hsp90 from forming multiprotein complexes. Studies are currently underway to determine whether EGCG competes with novobiocin or cisplatin binding. Taxol, a well-known drug for the treatment of cancer, is responsible for the stabilization of microtubules and the inhibition of mitosis. Previous studies have shown that taxol induces the activation of kinases and transcription factors, and mimics the effect of bacterial lipopolysaccharide (LPS), an attribute unrelated to its tubulin-binding properties. Rosen and coworkers prepared a biotinylated taxol derivative and performed affinity chromatography experiments with lysates from both mouse brain and macrophage cell lines. These studies led to identification of two chaperones, Hsp70 and Hsp90, by mass spectrometry. In contrast to typical Hsp90-binding drugs, taxol exhibits a stimulatory response. Recently it was reported that the geldanamycin derivative 17-AAG behaves synergistically with taxol-induced apoptosis. This review describes the different C-terminal inhibitors of Hsp90, with specific emphasis on structure – activity relationship studies of novobiocin and their effects on anti-proliferative activity. Keywords: Novobiocin, Inhibitors, Nucleotide- binding Pocket, proliferation, tumor cells, Hsp90, Gram-positive bacteria, lung cancer, antagonistic activity" @default.
• W2022254839 created "2016-06-24" @default.
• W2022254839 creator A5062921807 @default.
• W2022254839 creator A5072035580 @default.
• W2022254839 date "2008-11-01" @default.
• W2022254839 modified "2023-10-16" @default.
• W2022254839 title "Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket" @default.
• W2022254839 cites W103502886 @default.
• W2022254839 cites W1242125470 @default.
• W2022254839 cites W1479736651 @default.
• W2022254839 cites W153442697 @default.
• W2022254839 cites W1538013722 @default.
• W2022254839 cites W1541950149 @default.
• W2022254839 cites W1563031684 @default.
• W2022254839 cites W1625966995 @default.
• W2022254839 cites W1881688083 @default.
• W2022254839 cites W1955276614 @default.
• W2022254839 cites W1965038486 @default.
• W2022254839 cites W1969191453 @default.
• W2022254839 cites W1969642733 @default.
• W2022254839 cites W1971190195 @default.
• W2022254839 cites W1972299037 @default.
• W2022254839 cites W1972370905 @default.
• W2022254839 cites W1974029196 @default.
• W2022254839 cites W1974831163 @default.
• W2022254839 cites W1976220825 @default.
• W2022254839 cites W1976523749 @default.
• W2022254839 cites W1976980728 @default.
• W2022254839 cites W1980595299 @default.
• W2022254839 cites W1980792729 @default.
• W2022254839 cites W1980986250 @default.
• W2022254839 cites W1981310831 @default.
• W2022254839 cites W1983665072 @default.
• W2022254839 cites W1986511743 @default.
• W2022254839 cites W1987651883 @default.
• W2022254839 cites W1988999387 @default.
• W2022254839 cites W1991977835 @default.
• W2022254839 cites W1993657069 @default.
• W2022254839 cites W1995130557 @default.
• W2022254839 cites W1999307044 @default.
• W2022254839 cites W2000052684 @default.
• W2022254839 cites W2000109838 @default.
• W2022254839 cites W2004313928 @default.
• W2022254839 cites W2004792969 @default.
• W2022254839 cites W2007106751 @default.
• W2022254839 cites W2007652079 @default.
• W2022254839 cites W2008292539 @default.
• W2022254839 cites W2009020548 @default.
• W2022254839 cites W2009556803 @default.
• W2022254839 cites W2009899654 @default.
• W2022254839 cites W2009914246 @default.
• W2022254839 cites W2012816178 @default.
• W2022254839 cites W2013510760 @default.
• W2022254839 cites W2014044948 @default.
• W2022254839 cites W2017182956 @default.
• W2022254839 cites W2018024226 @default.
• W2022254839 cites W2020742237 @default.
• W2022254839 cites W2022531767 @default.
• W2022254839 cites W2023814104 @default.
• W2022254839 cites W2024306318 @default.
• W2022254839 cites W2025548430 @default.
• W2022254839 cites W2026771902 @default.
• W2022254839 cites W2028350610 @default.
• W2022254839 cites W2031431198 @default.
• W2022254839 cites W2033706352 @default.
• W2022254839 cites W2034269086 @default.
• W2022254839 cites W2034987223 @default.
• W2022254839 cites W2037490361 @default.
• W2022254839 cites W2037777917 @default.
• W2022254839 cites W2040691671 @default.
• W2022254839 cites W2041028263 @default.
• W2022254839 cites W2042699875 @default.
• W2022254839 cites W2046044279 @default.
• W2022254839 cites W2046626143 @default.
• W2022254839 cites W2046730500 @default.
• W2022254839 cites W2047143769 @default.
• W2022254839 cites W2048539342 @default.
• W2022254839 cites W2048983596 @default.
• W2022254839 cites W2049219332 @default.
• W2022254839 cites W2050159754 @default.
• W2022254839 cites W2051275249 @default.
• W2022254839 cites W2052151051 @default.
• W2022254839 cites W2054290614 @default.
• W2022254839 cites W2054712075 @default.
• W2022254839 cites W2055012138 @default.
• W2022254839 cites W2055345465 @default.
• W2022254839 cites W2055582545 @default.
• W2022254839 cites W2055976805 @default.
• W2022254839 cites W2057498265 @default.
• W2022254839 cites W2058138221 @default.
• W2022254839 cites W2058519323 @default.
• W2022254839 cites W2058570072 @default.
• W2022254839 cites W2059406989 @default.
• W2022254839 cites W2066264348 @default.
• W2022254839 cites W2067882412 @default.
• W2022254839 cites W2068435780 @default.
• W2022254839 cites W2068502127 @default.
• W2022254839 cites W2069816360 @default.

• next